Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention.
about
Specific small molecule inhibitors of Skp2-mediated p27 degradationIncorporation of protein flexibility and conformational energy penalties in docking screens to improve ligand discoveryNickel-catalyzed cross-couplings of benzylic pivalates with arylboroxines: stereospecific formation of diarylalkanes and triarylmethanes.Viral infection: an evolving insight into the signal transduction pathways responsible for the innate immune responseStructural revisions of small molecules reported to cross-link G-quadruplex DNA in vivo reveal a repetitive assignment error in the literaturePd(0)-catalyzed 1,1-diarylation of ethylene and allylic carbonates.Viral interference with innate immunity by preventing NF-κB activity.The Bcl-2 family: structures, interactions and targets for drug discovery.Resveratrol, sirtuins, and viruses.The vaccinia virus-encoded Bcl-2 homologues do not act as direct Bax inhibitors.Stereospecific nickel-catalyzed cross-coupling reactions of benzylic ethers and esters.Nickel-catalyzed cross couplings of benzylic ammonium salts and boronic acids: stereospecific formation of diarylethanes via C-N bond activation.A General, Simple Catalyst for Enantiospecific Cross Couplings of Benzylic Ammonium Triflates and Boronic Acids: No Phosphine Ligand RequiredAsymmetric transition metal-catalyzed cross-coupling reactions for the construction of tertiary stereocenters.Aldimine-directed branched-selective hydroarylation of styrenes.Nickel(0)-Catalyzed Hydroarylation of Styrenes and 1,3-Dienes with Organoboron Compounds.Suppression of Poxvirus Replication by Resveratrol.Enantioselective Intermolecular C-O Bond Formation in the Desymmetrization of Diarylmethines Employing a Guanidinylated Peptide-Based Catalyst.Direct cross-coupling of benzyl alcohols to construct diarylmethanes via palladium catalysis.Phosphine-catalyzed Friedel-Crafts reaction of naphthols with para-quinone methides: expedient access to triarylmethanes.Organocatalyzed Asymmetric Conjugate Addition of Heteroaryl and Aryl Trifluoroborates: a Synthetic Strategy for Discoipyrrole D.
P2860
Q24596988-64D5CF11-280A-400A-847E-A9F556755D37Q27684410-E373AA6A-4034-40E4-A26A-5CB6262AAF6CQ34446037-E52B1EBB-3E24-42A8-B7D2-7038AA064E67Q36246428-EF1797C4-B066-42BC-A637-36CB88E57FCAQ36719551-5A80219E-8B80-4505-8E0F-A30E5B2A15FAQ37638741-6CE7F100-DD31-4ED9-BD53-05CD6768B837Q37952350-EDC1DA29-30D4-4FCF-A9FD-2F3440D5A12DQ38268329-D82664AF-3469-48BE-95B0-673CF858D687Q38610855-6209BCE3-0E22-4A18-871B-686B046728C8Q39455647-6E373CE2-C89C-4086-A464-8F8D2B5CD8E5Q41762404-32B1C80E-CD25-43AB-81AC-C4C02A5474B9Q41839887-D6C608EB-1059-4613-9C14-D7F71831AC33Q42181224-C2753128-D176-48A2-B6DA-F13CC2A796F5Q42554304-CDDAA85C-BE93-4BB8-93CA-E17709DF16D5Q46127096-871AB414-786D-4503-8809-BB8186F1A52FQ46257339-A6A44B78-E47D-4F80-86AC-D426221ED77BQ47107948-9120C75E-F7C3-479D-95EE-B15A20D2FA19Q48341741-A3702C37-6455-4721-8C59-75B82663015AQ50441680-85A0421B-026C-4CF4-81CD-5DD4A16FC70BQ50872879-D731717B-139D-4056-9EBB-CEB035D59D1CQ50963584-22E59F63-7554-4E39-A079-014D58663EEA
P2860
Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Vaccinia virus virulence facto ...... iral therapeutic intervention.
@en
Vaccinia virus virulence facto ...... iral therapeutic intervention.
@nl
type
label
Vaccinia virus virulence facto ...... iral therapeutic intervention.
@en
Vaccinia virus virulence facto ...... iral therapeutic intervention.
@nl
prefLabel
Vaccinia virus virulence facto ...... iral therapeutic intervention.
@en
Vaccinia virus virulence facto ...... iral therapeutic intervention.
@nl
P2093
P2860
P356
P1476
Vaccinia virus virulence facto ...... iral therapeutic intervention.
@en
P2093
Alexander Aleshin
Andrey A Bobkov
Anton V Cheltsov
Dayong Zhai
Eric Chi-Wang Yu
John C Reed
Mika Aoyagi
Robert C Liddington
Taylor Gilliland
P2860
P304
P356
10.1021/JM901446N
P407
P577
2010-05-01T00:00:00Z